U.S. Communications Stock News

NYSE:CPAY
NYSE:CPAYDiversified Financial

Corpay (CPAY) Margin Slippage Tests Bullish Earnings Growth Narrative

Corpay (CPAY) just posted its FY 2025 results with Q4 revenue of US$1.2b and basic EPS of US$3.81, capped by trailing twelve month revenue of US$4.5b and EPS of US$15.25. The company has seen revenue move from US$1.0b in Q1 2025 to US$1.2b in Q4, while quarterly EPS ranged from US$3.46 to US$4.03 over the year, giving investors a clear view of how the top line and per share profitability have tracked through the fiscal period. With net profit margins easing over the past year, this latest...
NYSE:THG
NYSE:THGInsurance

Did Strong 2025 Earnings and Completed Buybacks Just Shift Hanover Insurance Group's (THG) Investment Narrative?

In early February 2026, The Hanover Insurance Group reported past fourth-quarter and full-year 2025 results showing higher revenue and net income year on year, alongside earnings per share that exceeded analyst expectations despite revenue landing slightly below some forecasts. At the same time, Hanover completed a long-running share repurchase program totaling 9,073,341 shares for about US$1.17 billion since 2018, highlighting an emphasis on shareholder returns alongside improved operating...
NYSE:JEF
NYSE:JEFCapital Markets

Is Jefferies Financial Group (JEF) Still Attractive After Recent Share Price Pullback?

If you are wondering whether Jefferies Financial Group at around US$56.51 is offering fair value or an opportunity, you are not alone. This article is built to help you frame that question clearly. The stock has recently been weak in the short term, with returns of a 7.7% decline over 7 days, a 14.7% decline over 30 days, and an 11.0% decline year to date. However, the 3 year and 5 year returns of 58.3% and 138.8% show a very different picture from a longer lens. Recent market commentary...
NYSE:AFL
NYSE:AFLInsurance

Aflac Weighs Massive Cyber Breach Against Dividend Growth And Buybacks

Aflac (NYSE:AFL) reported a major cybersecurity breach affecting personal data of about 22.65 million individuals. The company has begun notifying impacted customers and is monitoring for fraudulent activity linked to the incident. Alongside the breach disclosure, Aflac announced a 5.2% dividend increase and continued share repurchases. Aflac, a large provider of supplemental health and life insurance, now has two very different storylines for investors to watch: a significant data breach...
NYSE:WGO
NYSE:WGOAuto

Is Winnebago (WGO) Using Debt Reduction To Quietly Reposition Its Long‑Term Capital Strategy?

Winnebago Industries, Inc. recently announced it will redeem US$100,000,000 of its US$200,000,000 6.250% Senior Secured Notes due 2028 on February 20, 2026, at 100% of principal plus accrued and unpaid interest. This partial redemption highlights the company’s emphasis on balance sheet strength and financial flexibility, using available cash to reduce secured debt. Next, we’ll examine how this move to cut higher-cost secured debt influences Winnebago Industries’ broader investment...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

Alumis Ownership Shifts As Shelf Filing And Conferences Shape Outlook

BML Capital Management has exited its entire position in Alumis (NasdaqGS:ALMS). The move aligns with Alumis filing a new shelf registration. The company is also preparing to appear at several major investor conferences. BML Capital Management stepping away from Alumis puts fresh attention on how the market views the biotech name. Alumis, which focuses on drug development, now heads into a period where it is updating its capital markets toolkit through a shelf registration while also...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

Has The Recent Pullback In NXP Semiconductors (NXPI) Opened A Valuation Opportunity?

If you are wondering whether NXP Semiconductors' current share price lines up with its underlying worth, you are not alone. This article is built to help you judge that for yourself using clear valuation checks. The stock last closed at US$222.13, with a 4.9% decline over the past 7 days and a 9.7% decline over the past 30 days, while its year to date return is 0.4% and its 1 year return is 4.4%, compared with 23.8% over 3 years and 24.9% over 5 years. Recent attention on NXP Semiconductors...
NYSE:UBER
NYSE:UBERTransportation

Uber Technologies (UBER) Margin Compression Tests Bullish Valuation Narrative After FY 2025 Results

Uber Technologies (UBER) closed out FY 2025 with Q4 revenue of US$14.4b and basic EPS of US$0.14, alongside net income of US$296m, capping a year where trailing twelve month revenue reached US$52.0b and EPS came in at US$4.82. Over recent quarters, the company has seen revenue move from US$11.5b in Q1 2025 to US$13.5b in Q3 and then US$14.4b in Q4. Quarterly EPS shifted from US$0.85 in Q1 to US$3.18 in Q3 before landing at US$0.14 in the latest period, setting up a results season that puts...
NasdaqGS:ROP
NasdaqGS:ROPSoftware

Is It Time To Revisit Roper Technologies (ROP) After Its Recent Share Price Decline?

If you are wondering whether Roper Technologies is starting to look interesting at its current share price, this article will walk through what that might mean for you as an investor. The stock last closed at US$351.00, with returns of a 3.8% decline over 7 days, 19.6% decline over 30 days, 19.2% decline year to date, 39.4% decline over 1 year, 16.6% decline over 3 years, and 9.6% decline over 5 years. Recent news around Roper has focused on its positioning as a diversified software and...
NYSE:MTRN
NYSE:MTRNMetals and Mining

Is It Too Late To Consider Materion (MTRN) After Its Strong Share Price Run?

If you are trying to work out whether Materion’s share price still offers value at its current level, the key question is how that price lines up against what the business may be worth. The stock last closed at US$145.83, with returns of 2.8% over 7 days, 8.3% over 30 days, 13.5% year to date, 43.6% over 1 year, 73.7% over 3 years and 115.6% over 5 years. This naturally raises questions about how much of the story is already reflected in the price. Recent news coverage has focused on...
NYSE:APTV
NYSE:APTVAuto Components

Weighing Aptiv (APTV) After Mixed Returns And Conflicting Valuation Signals

If you are wondering whether Aptiv's current share price lines up with its underlying value, you are not alone. This article is designed to help you frame that question clearly. Aptiv's stock last closed at US$79.72, with returns of 1.1% over 7 days, a 3.5% decline over 30 days, 1.6% year to date, a 25.6% gain over 1 year, and declines of 31.3% and 48.2% over 3 and 5 years respectively. Taken together, these figures give a mixed signal about growth potential and risk perception. Recent...
NasdaqGM:GPCR
NasdaqGM:GPCRPharmaceuticals

Structure Therapeutics’ Oral Obesity Drug Enters Phase 2 As Investor Focus Grows

Structure Therapeutics (NasdaqGM:GPCR) has advanced its lead obesity candidate GSBR-1290 into phase 2 clinical trials as an oral treatment. The move comes as the company draws increased attention for targeting the obesity market with a pill-based approach rather than injectables. Analyst optimism and early discussion about potential takeovers have put fresh focus on the stock. Structure Therapeutics, trading under NasdaqGM:GPCR, is drawing fresh interest after pushing GSBR-1290 into phase...
NYSE:TNC
NYSE:TNCMachinery

Tennant Sets 2026 Meeting Timeline As Undervalued Shares Show Steady Gains

Tennant Company set the date for its 2026 annual meeting of shareholders. The company also announced the deadline for shareholders to nominate director candidates for the 2026 board election. The update outlines the timetable that will guide board nominations and voting for NYSE:TNC. Tennant, trading on the NYSE under ticker NYSE:TNC, recently closed at $80.84. The stock is up 5.5% over the past week, 5.0% over the past month, and 9.3% year to date, while showing a 4.1% decline over the...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

BioNTech Hire Signals People Focus As Oncology Plans And Valuation Attract Attention

BioNTech (NasdaqGS:BNTX) has created a new Chief People Officer role. Kylie Jimenez has been appointed to the position, effective immediately. The move is tied to BioNTech’s goal of becoming a multi product oncology leader beyond its COVID 19 work. BioNTech, known widely for its COVID 19 vaccine partnership, is working to build a broader pipeline in oncology and other therapeutic areas. The new Chief People Officer role indicates that leadership views talent, organizational design, and...
NYSE:NYT
NYSE:NYTMedia

New York Times (NYT) Margin Gains Reinforce Bullish Narratives Despite Premium P/E

The New York Times (NYT) closed out FY 2025 with Q4 revenue of US$802.3 million and basic EPS of US$0.80, compared with US$719.5 million of revenue and EPS of US$0.75 in the prior year’s Q4, pointing attention squarely to how efficiently the business is turning its top line into profit. Over the past six quarters, the company has seen quarterly revenue move from US$633.6 million in Q3 2024 to US$694.1 million in Q3 2025 and then to US$802.3 million in Q4 2025, while basic EPS ranged from...
NYSE:SRE
NYSE:SREIntegrated Utilities

Sempra Hydrogen Petition Seeks Faster Clarity On Future Gas Investments

Sempra subsidiaries Southern California Gas Co. and San Diego Gas & Electric have petitioned California regulators to drop a 5% hydrogen blending demonstration requirement. The filing argues that existing research and operational data are sufficient to assess low level hydrogen blending safety without new pilot projects. The request targets rules that would have required utilities to complete demonstration projects before regulators consider a systemwide hydrogen blending standard. Sempra,...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

FDA NDA Move Puts Exelixis Colorectal Cancer Bet To The Test

FDA accepts Exelixis' New Drug Application for zanzalintinib plus atezolizumab in metastatic colorectal cancer. The application is based on pivotal trial data for patients with advanced disease. This step moves the investigational combination closer to potential commercial use in the United States. For investors watching NasdaqGS:EXEL, this FDA filing milestone is an important datapoint in the company’s oncology pipeline. Exelixis focuses on cancer therapies, and colorectal cancer is a...
NYSE:ALL
NYSE:ALLInsurance

Allstate (ALL) Q4 Combined Ratio Of 80.1% Challenges Bearish Profitability Narratives

Allstate (ALL) just wrapped up FY 2025 with Q4 revenue of US$17.3b and basic EPS of US$14.55, capping off a trailing twelve month stretch where revenue reached US$67.7b and EPS came in at US$38.56 alongside year over year earnings growth of 123.4%. Over the past few quarters, the company has seen revenue move from US$16.5b and EPS of US$7.16 in Q4 2024 to US$16.6b and EPS of US$7.86 in Q2 2025, then to US$17.3b and EPS of US$14.55 in Q4 2025, setting up a story where stronger profitability...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

TPG Launches Third Wave Insurance As Earnings Mix Evolves

TPG (NasdaqGS:TPG) has launched Third Wave Insurance, a new retail insurance brokerage platform. The business is led by industry veteran Brian Bair and formed in partnership with Palmer & Cay. The move extends TPG beyond its traditional alternative asset management roots into insurance distribution. For investors watching TPG at a current share price of $53.54, this new insurance brokerage venture adds another business line alongside its existing funds platform. The stock has seen a 23.1%...
NYSE:LYB
NYSE:LYBChemicals

LyondellBasell Resets Portfolio And Capacity In Response To Tougher Cycle

LyondellBasell Industries (NYSE:LYB) is cutting global ethylene capacity and idling selected production through 2028 to address persistent weakness in chemicals markets. The company plans to divest four European assets as part of a broad portfolio overhaul aimed at focusing on higher value operations. These moves mark a clear inflection point for both LyondellBasell and the wider chemicals sector after a challenging period. LyondellBasell, trading at about $53.88, is taking these capacity...
NYSE:FLS
NYSE:FLSMachinery

Flowserve Expands Nuclear Power Reach With Trillium Valves Acquisition

Flowserve (NYSE:FLS) announced an agreement to acquire Trillium Flow Technologies’ Valves Division. The deal expands Flowserve’s reach in nuclear and traditional power markets. The acquisition is expected to be accretive to earnings within the year. Flowserve (NYSE:FLS) is a global provider of flow control products and services, with a core focus on pumps, valves and related support for critical infrastructure. By adding Trillium’s Valves Division, the company is set to broaden its product...